Repeated Imaginal Exposure for PTSD

This trial explores how adolescents with trauma-related symptoms react to stress and strong emotions. It focuses on repeated imaginal exposure, where participants repeatedly imagine details of a traumatic event, to determine if it alters anxiety levels or physiological responses like heart rate. The goal is to enhance understanding of trauma and identify predictors for who might benefit from exposure-based therapies for PTSD. Teens who recall a traumatic event and exhibit notable trauma symptoms might be suitable candidates. As an Early Phase 1 trial, this research aims to understand how the treatment works in people, offering participants a chance to contribute to groundbreaking insights into PTSD therapies.

If you are on psychotropic medications, you must be stabilized on them for at least four weeks before starting the study. This means you can continue taking your current medications as long as they have been stable for that period.

Studies have shown that imaginal exposure, such as the Script Driven Imagery (SDI) task used in this trial, is generally safe for people with PTSD. Research indicates that this type of exposure is well-tolerated, with most participants experiencing manageable anxiety levels that usually decrease over time.

Reports suggest that while some people may feel upset during sessions, this is a normal part of the process and not harmful in the long run. For example, one study found that imaginal exposure led to changes in anxiety and physical responses, like heart rate and sweating, which are expected during treatment.

Unlike traditional treatments for PTSD, which often include medications like SSRIs and therapeutic approaches like cognitive-behavioral therapy, the Script Driven Imagery (SDI) task focuses on repeated imaginal exposure. This technique involves patients vividly imagining distressing scenarios to help desensitize them and reduce the emotional impact of traumatic memories. Researchers are excited about this method because it directly targets the memory processing aspect of PTSD, potentially offering a more rapid and enduring reduction of symptoms by confronting and reprocessing specific traumatic events.

This trial will evaluate the effectiveness of repeated imaginal exposure, specifically using the Script Driven Imagery (SDI) task, for treating PTSD. Research has shown that imaginal exposure, which involves repeatedly imagining the details of a traumatic event, is a well-known method for treating PTSD. Studies have found that this technique can greatly reduce PTSD symptoms by helping people face and work through their traumatic memories. In some cases, imaginal exposure has been just as effective as other common PTSD treatments. It has been linked to noticeable improvements in anxiety and physical reactions, such as a slower heart rate and less sweating during stress. Overall, imaginal exposure is considered a promising way to manage PTSD symptoms.¹³⁶⁷⁸